Table 2

NOTCH1 mutations identified in patients from 2 independent AML cohorts

Patient no.AML cohortNOTCH1 mutation*Predicted amino acid change
2238 First 4741-4743del In-frame deletion of M1581 
3314 First 5036T>A, 7376ins37 bp L1679Q, L2458fsX2463 
2686 First 7552ins13 bp P2518fsX2523 
6947 Second 4790T>C L1597P 
7053 Second 4820del22/ins13 bp Mutation at aa 1607 FKRDAHGQ into SGRRP 
Patient no.AML cohortNOTCH1 mutation*Predicted amino acid change
2238 First 4741-4743del In-frame deletion of M1581 
3314 First 5036T>A, 7376ins37 bp L1679Q, L2458fsX2463 
2686 First 7552ins13 bp P2518fsX2523 
6947 Second 4790T>C L1597P 
7053 Second 4820del22/ins13 bp Mutation at aa 1607 FKRDAHGQ into SGRRP 

The first AML cohort represents the initial series of 285 cases. The second cohort represents the independent series of 268 AMLs, which was interrogated using a gene expression prediction signature.

*

Nucleotide numbering according to Entrez nucleotide accession number NM_017617 (version NM_017617.2). The mutations in patients no. 2238, no. 6947, and no. 7053 are located in the NOTCH1 HD domain (exons 26 and 27). The mutation in patient no. 2686 is located in the NOTCH1 PEST domain (exon 34). Patient no. 3314 harbors in cis mutations both in the HD domain as well as the PEST domain. All mutations identified are heterozygous.

Close Modal

or Create an Account

Close Modal
Close Modal